Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1998-02-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.95.4.1392PMID 9465025PMCID PMC19016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Influence of the Proliferating Cell Nuclear Antigen-interacting Domain of p21CIP1 on DNA Synthesis Catalyzed by the Human and Saccharomyces cerevisiae Polymerase δ Holoenzymes*

  1997cited by this paper
• New p57KIP2 mutations in Beckwith-Wiedemann syndrome

  1997cited by this paper
• Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

  1997cited by this paper
• Cyclin E-CDK2 is a regulator of p27Kip1.

  1997cited by this paper
• Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation

  1997cited by this paper
• Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome

  1997cited by this paper
• Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.

  1996cited by this paper
• An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA

  1995cited by this paper
• p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.

  1995cited by this paper
• Genomic imprinting of p57KIP2, a cyclin–dependent kinase inhibitor, in mouse

  1995cited by this paper
• Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

  1995cited by this paper
• Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

  1995cited by this paper
• A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1

  1995cited by this paper
• The genetics of Wilms' tumor--a case of disrupted development.

  1994cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

  1994cited by this paper
• Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

  1994cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• Comparative analysis of the expression and oncogenic activities of Xenopus c-, N-, and L-myc homologs

  1993cited by this paper
• Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants.

  1992cited by this paper

• Targeting the "Undruggable": Small-Molecule Inhibitors of Proliferating Cell Nuclear Antigen (PCNA) in the Spotlight in Cancer Therapy.

  2025cites this paper
• Transcription factor YY1 adversely governs ovarian granulosa cell growth in PCOS by transcription activation-mediated CDKN1C upregulation

  2024cites this paper
• p57Kip2 Phosphorylation Modulates Its Localization, Stability, and Interactions

  2024cites this paper
• CIP/KIP and INK4 families as hostages of oncogenic signaling

  2024cites this paper
• From cyclins to CDKIs: Cell cycle regulation of skeletal muscle stem cell quiescence and activation.

  2022cites this paper
• Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer.

  2021cites this paper
• p57 Suppresses the Pluripotency and Proliferation of Mouse Embryonic Stem Cells by Positively Regulating p53 Activation

  2021cites this paper
• A Beckwith–Wiedemann-Associated CDKN1C Mutation Allows the Identification of a Novel Nuclear Localization Signal in Human p57Kip2

  2021cites this paper
• Functional Versatility of the CDK Inhibitor p57Kip2

  2020cites this paper
• Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis

  2020cites this paper
• Pharmacological Stimulation of Nurr1 Promotes Cell Cycle Progression in Adult Hippocampal Neural Stem Cells

  2019cites this paper
• Dynamic Phosphorylation and Dephosphorylation of Cyclase-Associated Protein 1 by Antagonistic Signaling through Cyclin-Dependent Kinase 5 and cAMP Are Critical for the Protein Functions in Actin Filament Disassembly and Cell Adhesion

  2019cites this paper
• DNA Methylation and Its Role in the Development of Leukemia

  2019cites this paper
• Evolutionary Approach of Intrinsically Disordered CIP/KIP Proteins

  2019cites this paper
• MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN

  2018cites this paper
• Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases

  2018cites this paper
• Does cyclin E and p57kıp2 expression have prognostic and survival value in colorectal adenocarcinoma?

  2018cites this paper
• The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer

  2017cites this paper
• Identification, expression pattern and functional characterization of As-kip2 in diapause embryo restarting process of Artemia sinica.

  2017cites this paper
• CyclinD1 and p57kip2 as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma

  2017cites this paper
• Potential Antitumor Activity and Apoptosis Induction of Glossostemon bruguieri Root Extract against Hepatocellular Carcinoma Cells

  2017cites this paper
• CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability

  2017cites this paper
• Global increase in replication fork speed during a p57KIP2-regulated erythroid cell fate switch

  2016cites this paper
• Epigenetic Characterization of CDKN1C in Placenta Samples from Non-syndromic Intrauterine Growth Restriction

  2016influential citation
• Cell cycle heterogeneity as a regulator of epithelial bending during neural tube closure

  2016influential citation
• p57Kip2 knock‐in mouse reveals CDK‐independent contribution in the development of Beckwith–Wiedemann syndrome

  2016cites this paper
• KIAA0101 mRNA expression in the peripheral blood of hepatocellular carcinoma patients: Association with some clinicopathological features.

  2016cites this paper
• Short report Open Access

  2015cites this paper
• Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase

  2015cites this paper
• Fate modulation of oligodendroglial progenitor cells and adult neural stem cells

  2014cites this paper
• A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes.

  2014cites this paper
• Elevated CO_2 alleviates high PAR and UV stress in the unicellular chlorophyte Dunaliella tertiolecta

  2014cites this paper
• Study of the subcellular localization of cell cycle regulator Cks1 and its impact on cancer

  2014cites this paper
• Novel mutations of CDKN1C in Japanese patients with Beckwith-Wiedemann syndrome

  2013cites this paper
• Cyclin-Dependent Kinase 4 Phosphorylates and Positively Regulates PAX3-FOXO1 in Human Alveolar Rhabdomyosarcoma Cells

  2013cites this paper
• Insulin signaling and the regulation of insect diapause

  2013cites this paper
• Increased Protein Stability of CDKN1C Causes a Gain-of-Function Phenotype in Patients with IMAGe Syndrome

  2013cites this paper
• Epigenetic and genetic alterations of the imprinting disorder Beckwith–Wiedemann syndrome and related disorders

  2013cites this paper
• Intrinsic protein flexibility in regulation of cell proliferation: advantages for signaling and opportunities for novel therapeutics.

  2012cites this paper
• Gain of function in CDKN1C

  2012cites this paper
• The multiple roles of the cyclin‐dependent kinase inhibitory protein p57KIP2 in cerebral cortical neurogenesis

  2012cites this paper
• Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome

  2012cites this paper
• Disorder-function relationships for the cell cycle regulatory proteins p21 and p27

  2012cites this paper
• Characterization, Tissue Expression, and Imprinting Analysis of the Porcine CDKN1C and NAP1L4 Genes

  2012cites this paper
• Cell survival after UV radiation stress in the unicellular chlorophyte Dunaliella tertiolecta is mediated by DNA repair and MAPK phosphorylation

  2012cites this paper
• Effects of Prior Knowledge on Decisions Made Under Perceptual vs. Categorical Uncertainty

  2012cites this paper
• Mapping of CIP/KIP inhibitors, G1 cyclins D1, D3, E and p53 proteins in the rat term placenta

  2011cites this paper
• The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.

  2011cites this paper
• p57 and Cancer: Time for a Critical Appraisal

  2011cites this paper
• p57Kip2 and Cancer: Time for a Critical Appraisal

  2011cites this paper
• The nucleolar GTP-binding proteins Gnl2 and nucleostemin are required for retinal neurogenesis in developing zebrafish.

  2011cites this paper
• Differential effects of PPARgamma ligands on oxidative stress-induced death of retinal pigmented epithelial cells.

  2011cites this paper
• Tympanic membrane wound healing in rats assessed by transcriptome profiling

  2011cites this paper
• p57: A multifunctional protein in cancer (Review).

  2010cites this paper
• SLUG-induced Elevation of D1 Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination*

  2010cites this paper
• The beneficial effects of spirulina focusing on its immunomodulatory and antioxidant properties

  2010cites this paper
• CpG island methylator phenotype of cell-cycle regulators associated with TNM stage and poor prognosis in patients with oesophageal squamous cell carcinoma

  2010cites this paper
• Host cell factors in ovarian cancer influencing efficacy of oncolytic aenovirus dl922-947

  2010cites this paper
• Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model

  2009cites this paper
• p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells

  2009cites this paper
• The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics

  2009cites this paper
• p57KIP2: “Kip”ing the Cell under Control

  2009cites this paper
• p 57 KIP 2 : “ Kip ” ing the Cell under Control

  2009cites this paper
• Different expression patterns of p27KIP1 and p57KIP2 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes

  2009cites this paper
• Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57

  2008cites this paper
• Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment

  2008cites this paper
• Proliferating cell nuclear antigen: a proteomics view

  2008cites this paper
• Analyzing the effects of single and mixtures of potato glycoalkaloids on gene expression in intestinal epithelial cells

  2008cites this paper
• CDK inhibitors: cell cycle regulators and beyond.

  2008cites this paper
• Down-regulation of p57Kip2 induces prostate cancer in the mouse.

  2008cites this paper
• Differentiation and De-Differentiation—Neuronal Cell-Cycle Regulation During Development and Age-Related Neurodegenerative Disorders

  2008cites this paper
• Vitamin D 3 analogue EB 1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p 57

  2008cites this paper
• Role of the transcription factor NFAT5 in mammalian cell cycle regulation

  2008cites this paper
• Regulation of cell division by intrinsically unstructured proteins: intrinsic flexibility, modularity, and signaling conduits.

  2008cites this paper
• Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system.

  2007cites this paper
• Differential gene expression in intestinal epithelial cells induced by single and mixtures of potato glycoalkaloids.

  2007cites this paper
• Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate.

  2007cites this paper
• Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells.

  2007cites this paper
• Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism.

  2007cites this paper
• BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes.

  2007cites this paper
• Molecular basis for skeletal variation: insights from developmental genetic studies in mice.

  2007cites this paper
• The cell cycle inhibitor p57Kip2 promotes cell death via the mitochondrial apoptotic pathway

  2007cites this paper
• Simvastatin inactivates β1‐integrin and extracellular signal‐related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells

  2007cites this paper
• PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1

  2007cites this paper
• Overexpression of KIAA0101 Predicts High Stage, Early Tumor Recurrence, and Poor Prognosis of Hepatocellular Carcinoma

  2007cites this paper
• EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.

  2007cites this paper
• Tobacco proliferating cell nuclear antigen binds directly and stimulates both activity and processivity of ddNTP-sensitive mungbean DNA polymerase.

  2007cites this paper
• p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex.

  2006influential citation
• Protein phosphatase 1α activity prevents oncogenic transformation

  2006cites this paper
• Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.

  2006cites this paper
• An Evolutionarily Conserved Function of Proliferating Cell Nuclear Antigen for Cdt1 Degradation by the Cul4-Ddb1 Ubiquitin Ligase in Response to DNA Damage*

  2006cites this paper
• Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer

  2006cites this paper
• Differential expression of cyclin-dependent kinase inhibitors, p27Kip1 and p57Kip2, by corticotropin in rat adrenal cortex.

  2006cites this paper
• Protein phosphatase 1alpha activity prevents oncogenic transformation.

  2006cites this paper
• Ubiquitination of Cyclin-Dependent Kinase Inhibitor, Xic1, is Mediated by the Xenopus F-box Protein xSkp2

  2006cites this paper
• migration in the cerebral cortex independently promotes neuronal differentiation and kip1 p27

  2006cites this paper
• Cyclin-Dependent Kinase Inhibitors in Yeast, Animals, and Plants: A Functional Comparison

  2006cites this paper
• [p27Kip1 independently promotes neuronal differentiation and migration in the cerebral cortex].

  2006cites this paper
• Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues

  2005cites this paper
• Functional epigenomics identifies genes frequently silenced in prostate cancer.

  2005cites this paper